Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Uterine Cervical Neoplasms 1Tobacco Use Disorder 1Sexually Transmitted Diseases 1Breast Neoplasms 1

Interventions

Cyclophosphamide 909Carboplatin 787pembrolizumab 744Paclitaxel 742Cisplatin 709Bevacizumab 706Gemcitabine 619Docetaxel 579Rituximab 548Radiotherapy 541Dexamethasone 511Nivolumab 488Doxorubicin 444Fluorouracil 392Capecitabine 376Etoposide 358Pemetrexed 337Cytarabine 335Oxaliplatin 333Lenalidomide 328Prednisone 326fludarabine phosphate 316Erlotinib Hydrochloride 314Trastuzumab 300Leucovorin 299fludarabine 296Vincristine 287Filgrastim 284Bortezomib 284Cetuximab 276

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Has results × Community Health Workers × Clear all
NCT06289192 2025-09-10

Testing C-Raven, a Virtual Tobacco Cessation Intervention, in the Community

Johns Hopkins University

Phase 4 Completed
5 enrolled 8 charts

Tobacco Use Disorder

NCT03557801 2019-08-14

Promotora Navigator - Culturally Appropriate Patient Navigator

Vanderbilt University Medical Center

Phase NA Completed
101 enrolled 9 charts
Breast

Breast Neoplasms

NCT02157168 2019-04-05

Connecting Healthy Women: Examining the Effect of an Intervention From the Effect of Being Reachable

University of Arizona

Phase NA Completed
2,267 enrolled 13 charts
Gynecologic

Uterine Cervical Neoplasms, Sexually Transmitted Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡